Laboratory Corporation of America Holdings

183.40+0.3400+0.19%Vol 743.30K1Y Perf 7.06%
Sep 18th, 2020 16:00 DELAYED
BID178.26 ASK184.40
Open182.69 Previous Close183.06
Pre-Market- After-Market183.40
 - -%  - -%
Target Price
215.69 
Analyst Rating
Strong Buy 1.32
Potential %
17.61 
Finscreener Ranking
★★     46.51
Insiders Trans % 3/6/12 mo.
-100/-100/-85 
Value Ranking
     42.47
Insiders Value % 3/6/12 mo.
-100/-100/-99 
Growth Ranking
★★+     48.66
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-99 
Income Ranking
 —    -
Market Cap17.86B 
Earnings Rating
Strong Buy
Price Range Ratio 52W %
78.53 
Earnings Date
22nd Oct 2020

Today's Price Range

180.83184.53

52W Range

98.02206.74

5 Year PE Ratio Range

10.1033.30

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
1.06%
1 Month
0.38%
3 Months
12.97%
6 Months
60.16%
1 Year
7.06%
3 Years
19.99%
5 Years
53.60%
10 Years
144.66%

TickerPriceChg.Chg.%
LH183.400.34000.19
AAPL106.84-3.5000-3.17
GOOG1 459.99-35.5400-2.38
MSFT200.39-2.5200-1.24
XOM37.19-0.6100-1.61
WFC25.130.02000.08
JNJ149.182.01001.37
FB252.53-2.2900-0.90
GE6.88-0.1700-2.41
JPM98.35-0.2100-0.21
Financial StrengthValueIndustryS&P 500US Markets
0.90
1.10
0.45
0.97
3.60
Leverage Ratio 2.40
ProfitabilityValueIndustryS&P 500US Markets
27.30
7.30
12.50
10.30
3.05
RevenueValueIndustryS&P 500US Markets
11.47B
117.81
4.35
7.92
Earnings HistoryEstimateReportedSurprise %
Q02 20200.782.57229.49
Q01 20201.762.3734.66
Q04 20192.802.862.14
Q03 20192.842.902.11
Q02 20192.902.931.03
Q01 20192.532.623.56
Q04 20182.482.521.61
Q03 20182.872.74-4.53
Earnings Per EndEstimateRevision %Trend
9/2020 QR4.7654.55Positive
12/2020 QR4.287.00Positive
12/2020 FY13.8835.02Positive
12/2021 FY14.539.41Positive
Next Report Date22nd Oct 2020
Estimated EPS Next Report4.76
Estimates Count7
EPS Growth Next 5 Years %8.60
Volume Overview
Volume743.30K
Shares Outstanding97.40M
Trades Count11.08K
Dollar Volume231.42M
Avg. Volume953.39K
Avg. Weekly Volume578.63K
Avg. Monthly Volume864.08K
Avg. Quarterly Volume823.73K

Laboratory Corporation of America Holdings (NYSE: LH) stock closed at 183.4 per share at the end of the most recent trading day (a 0.19% change compared to the prior day closing price) with a volume of 775.64K shares and market capitalization of 17.86B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 61000 people. Laboratory Corporation of America Holdings CEO is Adam H. Schechter.

The one-year performance of Laboratory Corporation of America Holdings stock is 7.06%, while year-to-date (YTD) performance is 8.41%. LH stock has a five-year performance of 53.6%. Its 52-week range is between 98.02 and 206.74, which gives LH stock a 52-week price range ratio of 78.53%

Laboratory Corporation of America Holdings currently has a PE ratio of 49.60, a price-to-book (PB) ratio of 2.40, a price-to-sale (PS) ratio of 1.55, a price to cashflow ratio of 11.10, a PEG ratio of 2.32, a ROA of 2.05%, a ROC of 3.45% and a ROE of 5.03%. The company’s profit margin is 3.05%, its EBITDA margin is 12.50%, and its revenue ttm is $11.47 Billion , which makes it $117.81 revenue per share.

Of the last four earnings reports from Laboratory Corporation of America Holdings, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $4.76 for the next earnings report. Laboratory Corporation of America Holdings’s next earnings report date is 22nd Oct 2020.

The consensus rating of Wall Street analysts for Laboratory Corporation of America Holdings is Strong Buy (1.32), with a target price of $215.69, which is +17.61% compared to the current price. The earnings rating for Laboratory Corporation of America Holdings stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Laboratory Corporation of America Holdings has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Laboratory Corporation of America Holdings has a Buy technical analysis rating based on Technical Indicators (ADX : 25.23, ATR14 : 4.80, CCI20 : 81.84, Chaikin Money Flow : 0.16, MACD : -0.20, Money Flow Index : 55.25, ROC : 3.66, RSI : 52.94, STOCH (14,3) : 69.31, STOCH RSI : 0.28, UO : 55.90, Williams %R : -30.69), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Laboratory Corporation of America Holdings in the last 12-months were: Adam H. Schechter (Option Excercise at a value of $0), Brian J. Caveney (Option Excercise at a value of $0), D. Gary Gilliland (Option Excercise at a value of $0), David P. King (Option Excercise at a value of $0), David P. King (Sold 91 604 shares of value $14 982 432 ), Garheng Kong (Option Excercise at a value of $0), Glenn A. Eisenberg (Option Excercise at a value of $0), Jean-Luc Belingard (Option Excercise at a value of $239 289), Jean-Luc Belingard (Sold 26 479 shares of value $5 024 750 ), Judith C. Seltz (Buy at a value of $99 360), Kerrii B. Anderson (Option Excercise at a value of $256 074), Kerrii B. Anderson (Sold 2 600 shares of value $446 810 ), Lance V. Berberian (Option Excercise at a value of $0), Mark Schroeder (Option Excercise at a value of $0), Mark Schroeder (Sold 296 shares of value $55 091 ), Paul Kirchgraber (Option Excercise at a value of $0), Peter J. Wilkinson (Option Excercise at a value of $0), Peter J. Wilkinson (Sold 297 shares of value $56 326 ), Peter M. Neupert (Option Excercise at a value of $0), Richelle P. Parham (Option Excercise at a value of $0), Robert Sanders Williams (Option Excercise at a value of $128 037), Robert Sanders Williams (Sold 2 527 shares of value $456 333 ), Sandra D. van der Vaart (Option Excercise at a value of $0), Sandra D. van der Vaart (Sold 2 424 shares of value $414 529 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
11 (78.57 %)
9 (69.23 %)
8 (66.67 %)
Moderate Buy
1 (7.14 %)
1 (7.69 %)
1 (8.33 %)
Hold
2 (14.29 %)
3 (23.08 %)
3 (25.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.32
Strong Buy
1.50
Strong Buy
1.54

Laboratory Corporation of America Holdings

Laboratory Corporation of America is the nation's second- largest independent clinical laboratory, with roughly 20% of the independent lab market. The company operates more than 1,800 patient-service centers, offering a broad range of clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing. With the addition of Covance, LabCorp also has a sizable footprint in the global contract research organization market.

CEO: Adam H. Schechter

Teplephone: +1 336 229-1127

Address: 358 South Main Street, Burlington 27215, NC, USA

Number of employees: 61 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

57%43%

Bearish Bullish

40%60%

Bearish Bullish

51%49%

News

Stocktwits